Answers are grounded in this paper and cite their sources.
Seventeen patients with moderately active SLE participated in a double-blind, crossover study on the effect of MaxEPA, using olive oil as the control substance. During the first 3 months, 8/17 on Max EPA but only 2/17 on the control substance clinically and serologically improved (p = 0.05), but at 6 months there was no difference. The beneficial effect (if any) of MaxEPA on the disease was short-lived.
No takes yet. Share an insight, caveat, or question.
Westberg et al. (1990) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: